Cargando…
KRAS mutated Non‐Small Lung Carcinoma: A Real World Context from the Indian subcontinent
BACKGROUND: KRAS, although a common variant of occurrence (~20% of non‐small‐cell lung carcinoma [NSCLC]) has been untargetable, owing to the molecular structure which inherently prevents drug binding. KRAS mutations in NSCLC are associated with distinct clinical profiles including smokers and mucin...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939094/ https://www.ncbi.nlm.nih.gov/pubmed/36069080 http://dx.doi.org/10.1002/cam4.5193 |